Dr. Gia Mudd, RN, PhD
Claim this profileMore about Gia Mudd, RN, PhD
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Gia Mudd, RN, PhD has experience with
- Active Control Intervention Educational Sessions
- Family Dyad Intervention
Breakdown of trials Gia Mudd, RN, PhD has run
Risk Reduction Behavior
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gia Mudd, RN, PhD specialize in?
Gia Mudd, RN, PhD focuses on Risk Reduction Behavior and Type 2 Diabetes. In particular, much of their work with Risk Reduction Behavior has involved treating patients, or patients who are undergoing treatment.
Is Gia Mudd, RN, PhD currently recruiting for clinical trials?
No, Gia Mudd, RN, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Gia Mudd, RN, PhD has studied deeply?
Yes, Gia Mudd, RN, PhD has studied treatments such as Active Control Intervention educational sessions, Family Dyad Intervention.
What is the best way to schedule an appointment with Gia Mudd, RN, PhD?
Apply for one of the trials that Gia Mudd, RN, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.